Topics

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

17:13 EST 10 Nov 2019 | News-Medical.net

A new study found that very few serious infections were seen in children born to mothers with chronic inflammatory diseases who used non-TNFi biologics or tofacitinib during pregnancy compared to children not exposed to these drugs and children exposed to TNFi biologics in utero.

Original Article: Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

NEXT ARTICLE

More From BioPortfolio on "Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib"

Quick Search

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...